Articles dans des revues avec comité de lecture (111)
  1. 47. Botteaux, A., Budnik, I., & Smeesters, P. (2018). Group A Streptococcus infections in children: From virulence to clinical management. Current opinion in infectious diseases, 31(3), 224-230. doi:10.1097/QCO.0000000000000452
  2. 48. Jones, S., Moreland, N., Zancolli, M., Raynes, J., Loh, J. M. S., Smeesters, P., Sriskandan, S., Carapetis, J. R., Fraser, J. J., & Goldblatt, D. (2018). Development of an opsonophagocytic killing assay for group a streptococcus. Vaccine, 36(26), 3756-3763. doi:10.1016/j.vaccine.2018.05.056
  3. 49. Campbell, P. A., Frost, H., Smeesters, P., Kado, J., Good, M. F., Geard, N., Batzloff, M., McVernon, J., & Steer, A. C. (2018). Investigation of group A Streptococcus immune responses in an endemic setting, with a particular focus on J8. Vaccine, 36(50), 7618-7624. doi:10.1016/j.vaccine.2018.10.091
  4. 50. Frost, H., Sanderson-Smith, M. L., Walker, M. J., Botteaux, A., & Smeesters, P. (2017). group A streptococcal M-Like Proteins: From pathogenesis to Vaccine POTENTIAL. FEMS microbiology reviews. doi:10.1093/femsre/fux057
  5. 51. Frost, H. R. C. H., Laho, D., Sanderson-Smith, M. L., Licciardi, P., Donath, S., Curtis, N., Kado, J., Dale, J. B., Steer, A. C., & Smeesters, P. (2017). Immune Cross-Opsonization Within emm Clusters Following Group A Streptococcus Skin Infection: Broadening the Scope of Type-Specific Immunity. Clinical infectious diseases, 65(9), 1523-1531. doi:10.1093/cid/cix599
  6. 52. Wilkins, A. L., Steer, A. C., Smeesters, P., & Curtis, N. (2017). Toxic shock syndrome – the seven Rs of management and treatment. The Journal of infection, 74, S147-S152. doi:10.1016/S0163-4453(17)30206-2
  7. 53. Smeesters, P., Laho, D., Beall, B. W., Steer, A. C., & Van Beneden, C. C. (2017). Seasonal, geographic and temporal trends of imm-cluster associated with invasive group A Streptococcal infections in U.S. multi-state surveillance. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 64(5), 694-695.
  8. 54. Zühlke, L. J., Smeesters, P., Watkins, D., Zilla, P., Carapetis, J. R., Beaton, A., Engel, M. M., Hugo-Hamman, C. C., Karthikeyan, G., Katzenellenbogen, J. J., Ntusi, N., Ralph, A. A., & Saxena, A. (2017). Group A Streptococcus, Acute Rheumatic Fever and Rheumatic Heart Disease: Epidemiology and Clinical Considerations. Current treatment options in cardiovascular medicine, 19(2), 15. doi:10.1007/s11936-017-0513-y
  9. 55. Dale, J., Smeesters, P., Courtney, H. H., Penfound, T. T., Hohn, C. C., Smith, J. J., & Baudry, J. J. (2017). Structure-based design of broadly protective group a streptococcal M protein-based vaccines. Vaccine, 35(1), 19-26. doi:10.1016/j.vaccine.2016.11.065
  10. 56. Williamson, D. A., Smeesters, P., Steer, A. C., Morgan, J., Davies, M. R., Carter, P. P., Upton, A., Tong, S. S., Fraser, J., & Moreland, N. J. (2016). Comparative M-protein analysis of Streptococcus pyogenes from pharyngitis and skin infections in New Zealand: Implications for vaccine development. BMC infectious diseases, 16(1), 561. doi:10.1186/s12879-016-1891-6
  11. 57. Rattanavong, S., Smeesters, P., Dance, D. A. B., Davong, V., Baker, C. A., Frost, H. R. C. H., Phetsouvanh, R., Vongsouvath, M., Newton, P. P., & Steer, A. C. (2016). Group A streptococcal strains isolated in Lao People's Democratic Republic from 2004 to 2013. Epidemiology and infection, 144(8), 1770-1773. doi:10.1017/S0950268815002927
  12. 58. Steer, A. C., Carapetis, J. R., Dale, J. B., Fraser, J. D., Good, M. F., Guilherme, L., Moreland, N. J., Mulholland, E. K. I. E., Schodel, F., & Smeesters, P. (2016). Status of research and development of vaccines for Streptococcus pyogenes. Vaccine, 34(26), 2953-2958. doi:10.1016/j.vaccine.2016.03.073
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 Suivant >>